HALO logo
halo search icon
AC Immune SA

US$2.89

Price Change Indicator
0.07 (2.48%)
AC Immune SA
ACIU · NAS

AC Immune SA

Start Trading ACIU for Free

US$2.89

Price Arrow0.07 (2.48%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueHALO MomentumHammer Bullish
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

AC Immune SA Overview

ACIU Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ACIU

icon
icon

Telephone

41.21.345.91.21

icon

Address

Building B, EPFL Innovation Park, Lausanne, Vaud 1015

Description

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eliseev on February 13, 2003 and is headquartered in Lausanne, Switzerland.

ACIU Price Chart

Key Stats

Market Cap

US$287.00M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.6 - 4

Trade Value (12mth)

US$263,019.00

1 week

1.08%

1 month

-1.74%

YTD

-16.07%

1 year

70.91%

All time high

19.97

Key Fundamentals

EPS 3 yr Growth

-17.30%

EBITDA Margin

NaN%

Operating Cashflow

-SFr69m

Free Cash Flow Return

-87.80%

ROIC

-89.30%

Interest Coverage

-347.90

Quick Ratio

1.00

Other Data

Shares Outstanding (Fully Diluted)

0m

HALO Sector

Healthcare

Next Company Report Date

18-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

CHF

Short Sell (% of issue)

0.00

ACIU Announcements

Latest Announcements

DateAnnouncements
15 May 26
15 May 26
12 May 26
30 April 26
30 April 26

ACIU Fundamentals

Per Share Records

Historical data

Forecast data

CHF2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 SFrlocklocklocklock-0.64-0.51-0.7locklocklock
EPS (Fully Diluted)
 SFrlocklocklocklock-0.64-0.51-0.7locklocklock
Growth
 %locklocklocklock24.420.2-37locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of AC Immune SA (ACIU:NAS)?
Halo FAQ
The current share price of AC Immune SA (ACIU:NAS) is USD$2.89.
What is the 52-week high share price for AC Immune SA (ACIU:NAS)?
Halo FAQ
The 52-week high share price for AC Immune SA (ACIU:NAS) is USD$4.00.
What is the 52-week low share price for AC Immune SA (ACIU:NAS)?
Halo FAQ
The 52-week low share price for AC Immune SA (ACIU:NAS) is USD$1.60.
What is the dividend yield for AC Immune SA (ACIU:NAS)?
Halo FAQ
AC Immune SA (ACIU:NAS) does not pay a dividend.
What was AC Immune SA (ACIU:NAS) last dividend payment?
Halo FAQ
AC Immune SA (ACIU:NAS) does not pay a dividend.
What is the franking level for AC Immune SA (ACIU:NAS)?
Halo FAQ
AC Immune SA (ACIU:NAS) has a franking level of 0.00%.
In which sector is AC Immune SA (ACIU:NAS) classified?
Halo FAQ
AC Immune SA (ACIU:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial